• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Arteriovenous Malformation Market Share

    ID: MRFR/LS/3656-HCR
    100 Pages
    Kinjoll Dey
    October 2025

    Arteriovenous Malformation Market research report: by type (true arteriovenous malformation), diagnosis (physical examination, brain scans) treatment (endovascular embolization, neurosurgery), end user (hospitals & clinics) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Arteriovenous Malformation Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Arteriovenous Malformation Market Share Analysis

    The Arteriovenous Malformation (AVM) Market includes a complex condition with faulty artery-vein connections. AVM detection and treatment companies use a variety of strategies to succeed in this niche industry. Advanced diagnostic imaging is a key strategy. MRI, CTA, and DSA are advanced imaging modalities that companies invest in. Diagnostic excellence ensures AVM identification and market leadership. Strategic cooperation with interventional radiologists and neurosurgeons are essential. The company's AVM treatments are adopted through partnerships with prominent doctors. Medical expert relationships boost market reputation and referral networks. Because individuals choose less invasive AVM treatments, companies develop and promote these. Endovascular embolization, stereotactic radiosurgery, and other catheter-based treatments are examples. Giving patients fewer unpleasant options fits changing medical tastes and grows the industry. Companies participate in consumer and healthcare worker training. Knowledge of AVM, its symptoms, and treatment options improves understanding. Teaching clinicians about AVM therapies' benefits increases their utilization and market share. AVM market participants must follow tight legal requirements and participate in clinical investigations. Companies prioritize approvals and clinical trials to prove their AVM treatments are safe and effective. Following the guidelines and participating in clinical research boosts trust and market position. Targeting global markets is wise. Companies aim to have a significant presence in AVM-prone locations. Expanding to various countries improves market share and customers due to diverse healthcare systems and legislation. Telemedicine for AVM diagnosis and talks is modern. Companies are developing online specialist meetings for patients. Thus, patients can consult experts wherever. This strategy matches the telemedicine trend and simplifies patient care. Marketing must emphasize the urgency of finding and treating AVMs. Companies launch campaigns targeting healthcare professionals and the general public to raise awareness. Highlighting early evaluation's benefits affects the market's perception and increases early action. The strategy is to provide affordable AVM therapy. Businesses improve production methods, talk to suppliers, and consider economies of scale to lower pricing. This method attracts healthcare practitioners and organizations seeking reliable and cost-effective AVM treatment. We must provide healthcare personnel with continuing training. Through classes, webinars, and training materials, companies teach doctors about novel AVM treatments and equipment. Well-trained healthcare workers promote the company's products, changing the market's perception. Preventative measures include patient support and lobbying. Businesses create educational, resource, and mental support platforms for AVM sufferers and their families. This patient care boosts the company's reputation and keeps customers coming back.

    Market Summary

    As per Market Research Future Analysis, the Arteriovenous Malformation (AVM) Market was valued at USD 2.98 Billion in 2023 and is projected to grow to USD 5.41 Billion by 2032, with a CAGR of 5.96% from 2024 to 2032. AVMs are abnormal blood vessel tangles that disrupt normal blood flow, primarily affecting the brain and spine. The COVID-19 pandemic has introduced both challenges and opportunities, influencing market dynamics. Increased prevalence of neurological disorders and rising investments in biotechnology and pharmaceuticals are driving market growth. However, high treatment costs may restrain market expansion.

    Key Market Trends & Highlights

    The AVM market is witnessing significant growth driven by technological advancements and increased healthcare spending.

    • Market Size in 2023: USD 2.98 Billion.
    • Projected Market Size by 2032: USD 5.41 Billion.
    • CAGR from 2024 to 2032: 5.96%.
    • North America expected to dominate the market due to high healthcare spending.

    Market Size & Forecast

    2023 Market Size USD 2.98 Billion
    2024 Market Size USD 3.21 Billion
    2032 Market Size USD 5.41 Billion
    CAGR (2024-2032) 5.96%

    Major Players

    Toshiba Medical Systems Corporation (Japan), Fujifilm Holdings (Japan), Carestream Health (U.S.), Electrical Geodesics Inc. (U.S.), Nihon Kohden Corporation (Japan)

    Market Trends

    The increasing recognition of arteriovenous malformations as a critical health concern is driving advancements in diagnostic and therapeutic approaches, thereby enhancing patient outcomes and care strategies.

    National Institutes of Health (NIH)

    Arteriovenous Malformation Market Market Drivers

    Market Growth Projections

    The Global Arteriovenous Malformation Market Industry is projected to experience substantial growth, with estimates indicating a market value of 3.21 USD Billion in 2024 and a potential increase to 6.44 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 6.53% from 2025 to 2035, highlighting the increasing demand for effective treatments and interventions for AVMs. Various factors, including advancements in medical technology, rising prevalence, and government initiatives, are expected to contribute to this upward trend. The market's expansion presents opportunities for stakeholders to invest in research and development, ultimately improving patient care.

    Rising Awareness and Education

    Enhanced awareness and education regarding arteriovenous malformations are vital drivers for the Global Arteriovenous Malformation Market Industry. Increased public knowledge about AVMs leads to earlier diagnosis and treatment, which can significantly improve patient outcomes. Healthcare professionals are also receiving more training on recognizing and managing these conditions, further contributing to market growth. Educational initiatives by health organizations and patient advocacy groups play a crucial role in disseminating information. As awareness continues to rise, it is expected that more patients will seek treatment, thereby increasing demand for medical interventions and driving market expansion.

    Advancements in Medical Technology

    Technological innovations in the medical field are significantly influencing the Global Arteriovenous Malformation Market Industry. The development of minimally invasive surgical techniques and advanced imaging technologies has improved the diagnosis and treatment of AVMs. For instance, the introduction of robotic-assisted surgeries and enhanced imaging modalities allows for more precise interventions, reducing recovery times and improving patient outcomes. As these technologies become more widely adopted, they are likely to drive market growth. The anticipated market value of 6.44 USD Billion by 2035 reflects the potential impact of these advancements on treatment efficacy and patient care.

    Government Initiatives and Funding

    Government initiatives aimed at improving healthcare infrastructure and funding for research into vascular malformations are crucial for the Global Arteriovenous Malformation Market Industry. Various health authorities are allocating resources to enhance awareness, diagnosis, and treatment options for AVMs. For example, public health campaigns and funding for clinical trials can lead to better understanding and management of these conditions. Such initiatives not only support the development of new therapies but also encourage collaboration among healthcare providers, researchers, and patients. This collaborative environment is expected to foster innovation and drive market growth in the coming years.

    Growing Demand for Non-Invasive Treatment Options

    The increasing preference for non-invasive treatment options among patients is shaping the Global Arteriovenous Malformation Market Industry. Patients are increasingly seeking alternatives to traditional surgical procedures due to the associated risks and recovery times. Non-invasive techniques, such as endovascular embolization, are gaining traction as they offer effective treatment with fewer complications. This shift in patient preference is likely to drive market growth as healthcare providers adapt to meet these demands. The projected compound annual growth rate of 6.53% from 2025 to 2035 indicates a robust market response to the evolving treatment landscape.

    Increasing Prevalence of Arteriovenous Malformations

    The rising incidence of arteriovenous malformations (AVMs) globally is a pivotal driver for the Global Arteriovenous Malformation Market Industry. As awareness and diagnostic capabilities improve, more cases are identified, leading to a projected market value of 3.21 USD Billion in 2024. This increase in prevalence necessitates enhanced treatment options and healthcare resources, thereby stimulating market growth. Countries with advanced healthcare systems are particularly focused on developing innovative therapies and surgical techniques to manage AVMs effectively. The growing patient population is expected to drive demand for specialized medical devices and interventions, further contributing to the market's expansion.

    Market Segment Insights

    Regional Insights

    Key Companies in the Arteriovenous Malformation Market market include

    Industry Developments

      • The Asian Pacific region and country-wise market players are projected to emerge as the fastest-growing arteriovenous malformation market across the globe amid the rising market competition. Japan holds a major market share for being one of the most prominent places as the regional market due to the increasing availability of technology and huge healthcare spending owing to the rise in the disposable income of people in the APAC region.
      • The Middle East and Africa were holding the least share of the global market due to the limited availability of medical facilities during the historic forecast period that had ended in 2019. The countries, as a part of the region like UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market for the ongoing forecast period of 2024-2032.
      • The African region is expected to witness a moderate degree of growth owing to the rising developments that have been undertaken by the prominent industry players which is a result of the rising funds and investments.

    Future Outlook

    Arteriovenous Malformation Market Future Outlook

    The Global Arteriovenous Malformation Market is projected to grow at a 6.53% CAGR from 2024 to 2035, driven by advancements in treatment technologies and increasing awareness.

    New opportunities lie in:

    • Develop minimally invasive surgical techniques to enhance patient recovery.
    • Invest in AI-driven diagnostic tools for early detection of arteriovenous malformations.
    • Expand telemedicine services to improve patient access to specialized care.

    By 2035, the market is expected to demonstrate robust growth, reflecting advancements in treatment and increased patient engagement.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023 2.98 (USD Billion)
    Market Size 2024 3.21 (USD Billion)
    Market Size 2032 5.41 (USD Billion)
    Compound Annual Growth Rate (CAGR) 5.96 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Increasing prevalence of brain diseases/disorders·  Increasing investment by biotechnology and pharmaceutical industries in R&D·  Rising need for the better treatment methods

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth rate of the global arteriovenous malformation market?

    Arteriovenous malformation market is expected to exhibit a CAGR of 5.96% from 2024-2032.

    What are major drivers of the global arteriovenous malformation market?

    Rising prevalence of strokes and neurological disorders and investments by major biotechnology companies are major drivers of the global arteriovenous malformation market.

    Which region dominated in the global arteriovenous malformation market?

    The Americas can dominate the global arteriovenous malformation market due to a large healthcare expenditure and a large patient pool of brain disorders.

    Which region can showcase the least growth?

    The Middle East & Africa (MEA) can showcase the lowest growth rate in the global arteriovenous malformation market due to lack of funds and limited number of facilities.

    Name the notable players of the global arteriovenous malformation market?

    Toshiba Medical Systems Corporation, Fujifilm Holdings, Philips Healthcare, Carestream Health, Esaote, Shimadzu Corporation, Hologic, Masimo Corporation, GE Healthcare, Electrical Geodesics Inc., Siemens Healthcare, and Nihon Kohden Corporation are notable players of the global arteriovenous malformation market.

    1. Report Prologue
    2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary research
      4. 3.4
      5. Market Size Estimation
    4. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. 4.6
      7. Technology Trends & Assessment
    5. Market Factor Analysis
      1. Porters
        1. Bargaining Power of Suppliers
        2. Bargaining
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Five Forces Analysis
      3. Power of Buyers
      4. Value Chain Analysis
      5. Investment
      6. Feasibility Analysis
      7. Pricing Analysis
    6. Global Arteriovenous Malformation
    7. Market, by Type
      1. Introduction
      2. True Arteriovenous Malformation
        1. Market Estimates & Forecast, 2020-2027
      3. Occult or Cryptic AVM
        1. Market Estimates & Forecast, 2020-2027
      4. or Cavernous Malformations
    8. Global Arteriovenous Malformation Market, by Diagnosis
      1. Introduction
      2. Physical examination
        1. Market Estimates & Forecast, 2020-2027
      3. Brain Scans
        1. Market Estimates & Forecast, 2020-2027
        2. Market Estimates & Forecast, 2020-2027
      4. 7.4
      5. Others
    9. Global Arteriovenous
    10. Malformation Market, by Treatment
      1. Introduction
      2. Endovascular Embolization
        1. Market Estimates & Forecast, 2020-2027
      3. Neurosurgery
      4. 8.3.1
      5. Market Estimates & Forecast, 2020-2027
    11. Global Arteriovenous Malformation
    12. Market, by End User
      1. Introduction
      2. Hospitals & clinics
      3. 9.2.1
      4. Market Estimates & Forecast, 2020-2027
      5. Research laboratories
      6. 9.3.1
      7. Market Estimates & Forecast, 2020-2027
      8. Others
        1. Market Estimates
      9. & Forecast, 2020-2027
    13. Global Arteriovenous Malformation Market, by
      1. Region
      2. Introduction
      3. Americas
        1. North America
        2. South America
      4. 10.2.1.1
      5. US
      6. Europe
        1. Western
        2. Eastern
      7. Europe
      8. 10.3.1.4
      9. Italy
      10. Europe
      11. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic of Korea
        6. Rest of Asia Pacific
      12. The Middle East & Africa
        1. United Arab Emirates
        2. Oman
        3. Kuwait
        4. Qatar
        5. Rest
      13. 10.5.2
      14. Saudi Arabia
      15. of the Middle East & Africa
    14. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    15. Company Profiles
      1. Fujifilm Holdings
        1. Company Overview
        2. Product Overview
        3. Financials
        4. SWOT Analysis
      2. GE Healthcare
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Siemens Healthcare
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Philips Healthcare
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. Shimadzu Corporation
        1. Company Overview
        2. Product Overview
        3. Financial overview
        4. Key Developments
      6. Toshiba Medical Systems Corporation
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
      7. Carestream Health
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Others
    16. MRFR Conclusion
      1. 13.1
      2. Key Findings
      3. the Market
      4. Industry
    17. From CEO’s View Point
    18. Unmet Needs of
      1. Key Companies to Watch
      2. Prediction of Pharmaceutical
    19. Appendix
    20. LIST OF TABLES
    21. Arteriovenous
      1. Malformation Industry Synopsis, 2020-2027
    22. Global Arteriovenous Malformation
      1. Market Estimates and Forecast, 2020-2027, (USD Million)
    23. Global Arteriovenous
      1. Malformation Market by Region, 2020-2027, (USD Million)
    24. Global Arteriovenous
      1. Malformation Market by Types, 2020-2027, (USD Million)
    25. Global Arteriovenous
      1. Malformation Market by Diagnosis, 2020-2027, (USD Million)
    26. Global Arteriovenous
      1. Malformation Market by Treatment, 2020-2027, (USD Million)
    27. Global Arteriovenous
      1. Malformation Market by End Users, 2020-2027, (USD Million)
    28. North America
      1. Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)
      2. Table
    29. North America Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD
      1. Million)
    30. North America Arteriovenous Malformation Market by Treatment,
    31. North America Arteriovenous Malformation
      1. Market by End Users, 2020-2027, (USD Million)
    32. US Arteriovenous Malformation
      1. Market by Types, 2020-2027, (USD Million)
    33. US Arteriovenous Malformation
      1. Market by Diagnosis, 2020-2027, (USD Million)
    34. US Arteriovenous Malformation
      1. Market by Treatment, 2020-2027, (USD Million)
    35. US Arteriovenous Malformation
      1. Market by End Users, 2020-2027, (USD Million)
    36. Canada Arteriovenous
      1. Malformation Market by Types, 2020-2027, (USD Million)
    37. Canada Arteriovenous
      1. Malformation Market by Diagnosis, 2020-2027, (USD Million)
    38. Canada
      1. Arteriovenous Malformation Market by Treatment, 2020-2027, (USD Million)
      2. Table
    39. Canada Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)
    40. South America Arteriovenous Malformation Market by Types, 2020-2027,
      1. (USD Million)
    41. South America Arteriovenous Malformation Market by Diagnosis,
    42. South America Arteriovenous Malformation
      1. Market by Treatment, 2020-2027, (USD Million)
    43. South America Arteriovenous
      1. Malformation Market by End Users, 2020-2027, (USD Million)
    44. Europe
      1. Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)
      2. Table
    45. Europe Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)
    46. Europe Arteriovenous Malformation Market by Treatment, 2020-2027, (USD
      1. Million)
    47. Europe Arteriovenous Malformation Market by End Users, 2020-2027,
      1. (USD Million)
    48. Western Europe Arteriovenous Malformation Market by
      1. Types, 2020-2027, (USD Million)
    49. Western Europe Arteriovenous Malformation
      1. Market by Diagnosis, 2020-2027, (USD Million)
    50. Western Europe Arteriovenous
      1. Malformation Market by Treatment, 2020-2027, (USD Million)
    51. Western
      1. Europe Arteriovenous Malformation Market by End Users, 2020-2027, (USD Million)
    52. Eastern Europe Arteriovenous Malformation Market by Types, 2020-2027,
      1. (USD Million)
    53. Eastern Europe Arteriovenous Malformation Market by
      1. Diagnosis, 2020-2027, (USD Million)
    54. Eastern Europe Arteriovenous Malformation
      1. Market by Treatment, 2020-2027, (USD Million)
    55. Eastern Europe Arteriovenous
      1. Malformation Market by End Users, 2020-2027, (USD Million)
    56. Asia Pacific
      1. Arteriovenous Malformation Market by Types, 2020-2027, (USD Million)
      2. Table
    57. Asia Pacific Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD
      1. Million)
    58. Asia Pacific Arteriovenous Malformation Market by Treatment,
    59. Asia Pacific Arteriovenous Malformation Market
      1. by End Users, 2020-2027, (USD Million)
    60. Middle East & Africa Arteriovenous
      1. Malformation Market by Types, 2020-2027, (USD Million)
    61. Middle East
      1. & Africa Arteriovenous Malformation Market by Diagnosis, 2020-2027, (USD Million)
    62. Middle East & Africa Arteriovenous Malformation Market by Treatment,
    63. Middle East & Africa Arteriovenous Malformation
      1. Market by End Users, 2020-2027, (USD Million)
    64. LIST OF FIGURES
    65. Research Process
    66. Segmentation for Global Arteriovenous
      1. Malformation Market
    67. Segmentation Market Dynamics for Arteriovenous
      1. Malformation Market
    68. Global Arteriovenous Malformation Market Share,
      1. by Diagnosis 2020
    69. Global Arteriovenous Malformation Market Share,
      1. by Treatment 2020
    70. Global Arteriovenous Malformation Market Share,
      1. by End Users, 2020
    71. Global Arteriovenous Malformation Market Share,
      1. by Region, 2020
    72. North America Arteriovenous Malformation Market Share,
      1. by Country, 2020
    73. Europe Arteriovenous Malformation Market Share, by
      1. Country, 2020
    74. Asia Pacific Arteriovenous Malformation Market Share,
      1. by Country, 2020
    75. Middle East & Africa Arteriovenous Malformation
    76. Market Share, by Country, 2020
    77. Global Arteriovenous Malformation
      1. Market: Company Share Analysis, 2020 (%)
    78. Fujifilm Holdings: Key Financials
    79. Fujifilm Holdings: Segmental Revenue
    80. Fujifilm Holdings:
      1. Geographical Revenue
    81. GE Healthcare: Key Financials
      1. Figure 17
      2. GE Healthcare: Segmental Revenue
    82. GE Healthcare: Geographical Revenue
    83. Siemens Healthcare: Key Financials
    84. Siemens Healthcare:
      1. Segmental Revenue
    85. Siemens Healthcare: Geographical Revenue
      1. Figure
    86. Philips Healthcare: Key Financials
    87. Philips Healthcare: Segmental
      1. Revenue
    88. Philips Healthcare: Geographical Revenue
    89. Shimadzu
      1. Corporation.: Key Financials
    90. Shimadzu Corporation: Segmental Revenue
    91. Shimadzu Corporation: Geographical Revenue
    92. Toshiba Medical
      1. Systems Corporation: Key Financials
    93. Toshiba Medical Systems Corporation:
      1. Segmental Revenue
    94. Toshiba Medical Systems Corporation: Geographical
      1. Revenue
    95. Carestream Health.: Key Financials
    96. Carestream
      1. Health: Segmental Revenue
    97. Carestream Health: Geographical Revenue

    Arteriovenous Malformation Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027